↓ Skip to main content

Dove Medical Press

Article Metrics

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, June 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source
twitter
4 tweeters

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
40 Mendeley
Title
Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
Published in
International Journal of Chronic Obstructive Pulmonary Disease, June 2012
DOI 10.2147/copd.s31100
Pubmed ID
Authors

Stine Ohlendorff, Martinez, Fabbri, Goehring, Klaus Rabe, Peter Calverley

Abstract

Many patients with chronic obstructive pulmonary disease (COPD) continue to suffer exacerbations, even when treated with maximum recommended therapy (eg, inhaled combinations of long-acting β2-agonist and high dose inhaled corticosteroids, with or without a long-acting anticholinergic [long-acting muscarinic antagonist]). Roflumilast is approved to treat severe COPD in patients with chronic bronchitis--and a history of frequent exacerbations--as an add-on to bronchodilators.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Spain 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 20%
Student > Master 7 18%
Professor 5 13%
Student > Bachelor 4 10%
Student > Ph. D. Student 3 8%
Other 6 15%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 20 50%
Agricultural and Biological Sciences 5 13%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Economics, Econometrics and Finance 1 3%
Other 0 0%
Unknown 10 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2018.
All research outputs
#4,351,383
of 15,826,755 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#540
of 1,855 outputs
Outputs of similar age
#33,548
of 128,664 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#9
of 34 outputs
Altmetric has tracked 15,826,755 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 1,855 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,664 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.